1. Acknowledgement to Referees

   Acknowledgments 13 November 2020 Pages: 363 - 364

2. The Pharmaceutical Year That Was, 2020

   • Anthony W. Fox

   Editorial 08 December 2020 Pages: 365 - 368

   

3. The Unintended Consequences of Adverse Event Information on Medicines’ Risks and Label Content

   • Giovanni Furlan
   • David Power

   Current Opinion 16 November 2020 Pages: 369 - 380

   

4. Current Challenges in Labelling for Generic Medicinal Products: Company Core Data Sheet (CCDS) Development and Maintenance

   • Marion Mueller
   • David J. Lewis
   • Sebastian Horn

   Current Opinion Open access 08 December 2020 Pages: 381 - 386

5. Risk Minimisation Evaluation with Process Indicators and Behavioural or Health Outcomes in Europe: Systematic Review

   • Esther Artime
   • Nawab Qizilbash
   • Macarena Garrido-Estepa

   Systematic Review 03 November 2020 Pages: 387 - 400

   

6. Plain Language Summaries of Clinical Trial Results: A Preliminary Study to Assess Availability of Easy-to-Understand Summaries and Approaches to Improving Public Engagement

   • Michael Penlington
   • Harold Silverman
   • Priya Pavithran

   Short Communication Open access 28 October 2020 Pages: 401 - 406

7. Forum

   Update 25 November 2020 Pages: 407 - 413

8. Major Pharmaceutical Conferences and Courses: February to March 2021

   Update 25 November 2020 Pages: 415 - 416